| Date Filed | Type | Description |
| 06/17/2022 |
4
| Ross Michael Jay (Director) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Granted 13,200 options to buy
@ $2.28, valued at
$30.1k
|
|
| 10/25/2021 |
4
| Ross Michael Jay (Director) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Granted 26,400 options to buy
@ $16, valued at
$422.4k
|
|
| 10/21/2021 |
3
| Ross Michael Jay (Director) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 06/13/2019 |
4
| Ross Michael Jay (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 12,000 options to buy
@ $21.05, valued at
$252.6k
|
|
| 10/01/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/11/2018 |
4
| Ross Michael Jay (Director) has filed a Form 4 on Ophthotech Corp.|
Txns:
| Granted 16,000 options to buy
@ $2.775, valued at
$44.4k
|
|
| 06/07/2018 |
4
| Ross Michael Jay (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 14,000 options to buy
@ $1.48, valued at
$20.7k
|
|
| 06/07/2018 |
4
| Ross Michael Jay (Director) has filed a Form 4 on Arsanis, Inc.|
Txns:
| Granted 10,000 options to buy
@ $16.99, valued at
$169.9k
|
|
| 05/21/2018 |
4
| Ross Michael Jay (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 12,000 options to buy
@ $25.73, valued at
$308.8k
|
|
| 03/28/2018 |
3/A
| Ross Michael Jay (Director) has filed a Form 3/A on Deciphera Pharmaceuticals, Inc. |
| 03/05/2018 |
4/A
| Ross Michael Jay (Director) has filed a Form 4 on Arsanis, Inc.|
Txns:
| Granted 25,000 options to buy
@ $10, valued at
$250k
|
|
| 12/01/2017 |
4
| Ross Michael Jay (10% Owner) has filed a Form 4 on Arsanis, Inc.|
Txns:
| Granted 7,324 options to buy
@ $10, valued at
$73.2k
|
|
| 11/20/2017 |
4
| Ross Michael Jay (10% Owner) has filed a Form 4 on Arsanis, Inc.|
Txns:
| Converted 19,128 shares
@ $0
Converted 404 shares
@ $0
Converted 247,010 shares
@ $0
Converted 5,219 shares
@ $0
Converted 322,102 shares
@ $0
Converted 6,806 shares
@ $0
Converted 111,955 shares
@ $0
Converted 2,365 shares
@ $0
Converted 202,915 shares
@ $0
Converted 4,288 shares
@ $0
Converted 431,980 shares
@ $0 |
|
| 11/15/2017 |
3
| Ross Michael Jay (10% Owner) has filed a Form 3 on Arsanis, Inc. |
| 07/28/2017 |
4
| ROSS MICHAEL JAY (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 6,500 options to buy
@ $1.27, valued at
$8.3k
|
|
| 05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/25/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |